Streetbeat News

Price Targets

MKTX

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on MarketAxess Holdings (NASDAQ:MKTX) and raises the price target from $237 to $268.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:58 pm

MRX

Barclays analyst Benjamin Budish maintains an Overweight rating on Marex Group (NASDAQ:MRX) and raises the price target from $28 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:56 pm

KKR

Barclays analyst Benjamin Budish maintains an Overweight rating on KKR and raises the price target from $146 to $149.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:54 pm

ICE

Barclays analyst Benjamin Budish has maintained an Overweight rating on Intercontinental Exchange (NYSE:ICE) and raised the price target from $167 to $179.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:53 pm

IBKR

Barclays analyst Benjamin Budish has maintained an Overweight rating on Interactive Brokers Group (NASDAQ:IBKR) and raised the price target from $147 to $166.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:50 pm

CME

Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group (NASDAQ:CME) and raises the price target from $209 to $219.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:48 pm

CBOE

Barclays analyst Benjamin Budish maintains an Overweight rating on Cboe Global Markets and raises the price target from $218 to $239.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:45 pm

CON

Concentra Group Holdings shares fell after B of A Securities downgraded the stock from Buy to Neutral and reduced its price target from $30.5 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:45 pm

BMY

Barclays analyst Carter Gould maintains an Underweight rating on Bristol-Myers Squibb (NYSE:BMY) but raises the price target from $42 to $43.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:42 pm

ACCD

Accolade shares are experiencing an upward trend following Needham's reiteration of a Buy rating and a maintained price target of $8.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:41 pm